Comparison of Double and Triple High‐Dose Chemotherapy with Autologous Blood Stem Cell Transplantation in Patients with Metastatic Breast Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of Double and Triple High‐Dose Chemotherapy with Autologous Blood Stem Cell Transplantation in Patients with Metastatic Breast Cancer

Published:2001-03 Issue:2 Volume:19 Page:151-160
ISSN:1066-5099
Container-title:STEM CELLS
language:en
Short-container-title:STEM CELLS

Author:

Schneeweiss A.¹,Hensel M.²,Goerner R.¹,Khbeis T.¹,Hohaus S.²,Egerer G.²,Solomayer E.¹,Haas R.³,Grischke E.‐M.¹,Bastert G.¹,Ho A. D.²

Affiliation:

1. Department of Gynecology and Obstetrics, University of Heidelberg, Heidelberg, Germany

2. Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany

3. Department of Hematology and Oncology, University of Düsseldorf, Düsseldorf, Germany

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,Developmental Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/stemcells.19-2-151

Reference30 articles.

1. Overview of new treatments for breast cancer

2. Chemotherapy of advanced breast cancer: outcome and prognostic factors

3. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer.

4. The importance of dose intensity in chemotherapy of metastatic breast cancer.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy;Cytokine;2004-07

2. Ifosfamide in Advanced/Disseminated Breast Cancer;Oncology;2003

3. Characteristics associated withlong-term progression-free survival following high-dose chemotherapyin metastatic breast cancer and influence of chemotherapy dose;Annals of Oncology;2002-05

4. Stem Cell Dose and Tumorbiologic Parameters as Prognostic Markers for Patients with Metastatic Breast Cancer Undergoing High-Dose Chemotherapy with Autologous Blood Stem Cell Support;Stem Cells;2002-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3